presentation, harvard, value based care
DESCRIPTION
Presentation at Harvard, ISC, 2011TRANSCRIPT
![Page 1: Presentation, Harvard, Value Based Care](https://reader036.vdocuments.net/reader036/viewer/2022070317/556e6eefd8b42a795d8b4746/html5/thumbnails/1.jpg)
Operationalizing value in Chronic Care: The case of Swedish Rheumatology
A research project involving Karolinska Institutet/Medical Management Center, Stockholm University School of Business, Karolinska University Hospital, Stockholm County Council and
Harvard Business School.
![Page 2: Presentation, Harvard, Value Based Care](https://reader036.vdocuments.net/reader036/viewer/2022070317/556e6eefd8b42a795d8b4746/html5/thumbnails/2.jpg)
2
The cycle of disease: Rheumatoid Arthritis
REHAB- SERVICES
Lifestyle & self-medication
- SPECIALIST CARELAB TESTS
X-RAY
HOSPITALIZATIONS
![Page 3: Presentation, Harvard, Value Based Care](https://reader036.vdocuments.net/reader036/viewer/2022070317/556e6eefd8b42a795d8b4746/html5/thumbnails/3.jpg)
3
DAS28 (Disease Activity)
Time
![Page 4: Presentation, Harvard, Value Based Care](https://reader036.vdocuments.net/reader036/viewer/2022070317/556e6eefd8b42a795d8b4746/html5/thumbnails/4.jpg)
4
Disease cycle captured in the SRQ registry
![Page 5: Presentation, Harvard, Value Based Care](https://reader036.vdocuments.net/reader036/viewer/2022070317/556e6eefd8b42a795d8b4746/html5/thumbnails/5.jpg)
5
REHAB- SERVICES
Disease cycle captured in the SRQ registry
![Page 6: Presentation, Harvard, Value Based Care](https://reader036.vdocuments.net/reader036/viewer/2022070317/556e6eefd8b42a795d8b4746/html5/thumbnails/6.jpg)
6
Capturing the entire disease cycle
![Page 7: Presentation, Harvard, Value Based Care](https://reader036.vdocuments.net/reader036/viewer/2022070317/556e6eefd8b42a795d8b4746/html5/thumbnails/7.jpg)
7
Prioritizing measures based on the stage of the disease: defining two phases
![Page 8: Presentation, Harvard, Value Based Care](https://reader036.vdocuments.net/reader036/viewer/2022070317/556e6eefd8b42a795d8b4746/html5/thumbnails/8.jpg)
8
First phase of disease: reaching low or no disease activity
Early & aggressive treatment
Aims, phase 1
• Response by DAS28CRP or patients global
• Treatment to reach low or no disease activity
![Page 9: Presentation, Harvard, Value Based Care](https://reader036.vdocuments.net/reader036/viewer/2022070317/556e6eefd8b42a795d8b4746/html5/thumbnails/9.jpg)
9
Maintain low DAS28
•Aims, phase 2
•Low level of disease activity (Area under the curve, AUC), •Patient satisfaction with outcomes: trust in care, quality of life (EQ5D/QALY)
Second phase: long-term management and prevention
![Page 10: Presentation, Harvard, Value Based Care](https://reader036.vdocuments.net/reader036/viewer/2022070317/556e6eefd8b42a795d8b4746/html5/thumbnails/10.jpg)
10
Detect and curb flares
Second phase: long-term management and prevention
•Number, intensity and duration of recurrences (flares).
![Page 11: Presentation, Harvard, Value Based Care](https://reader036.vdocuments.net/reader036/viewer/2022070317/556e6eefd8b42a795d8b4746/html5/thumbnails/11.jpg)
11
RA outcome measures in the three tiers
Survival – Mortality Health / recovery – Patients global, EQ-5D, Work ability, Daily
function,DAS28, AUC Doctors global
Time to recovery – Time to remission, time to work ability regained
Disutility of care / Rx – Trust in care, Drug adverse events Continuity, empathy, access etc?
Sustainability of health / flares – Health / recovery AUC Long-term consequences of therapy – Patients global, EQ-5D,
Work ability, Daily function,DAS28, AUC Doctors global, adverse events, co-morbidities
Control for case-mix variables (gender, age, biomarkers, socio-economic status etc)
![Page 12: Presentation, Harvard, Value Based Care](https://reader036.vdocuments.net/reader036/viewer/2022070317/556e6eefd8b42a795d8b4746/html5/thumbnails/12.jpg)
12
![Page 13: Presentation, Harvard, Value Based Care](https://reader036.vdocuments.net/reader036/viewer/2022070317/556e6eefd8b42a795d8b4746/html5/thumbnails/13.jpg)
13
Cost per patient - RA 2009Karolinska data
Costs – not charges
Number of out-patient visits 45 404
Total cost 157 692 215 SEK Medical service 9 481 442 SEK Operation 1 917 123 SEK ICU 13 311 SEK Drugs 93 835 356 SEK Visits 52 444 983 SEK
![Page 14: Presentation, Harvard, Value Based Care](https://reader036.vdocuments.net/reader036/viewer/2022070317/556e6eefd8b42a795d8b4746/html5/thumbnails/14.jpg)
14
Costs – micro level
Stockholm County Council data sources: In-patient and out-patient data and cost per patient (CPP). Figures will be added.
![Page 15: Presentation, Harvard, Value Based Care](https://reader036.vdocuments.net/reader036/viewer/2022070317/556e6eefd8b42a795d8b4746/html5/thumbnails/15.jpg)
15
Questions to discuss
Delimiting the medical condition and care cycle Using the available data to operationalize value
Prioritizing outcomes and cost measures Ensuring that measures are useful and acted upon
Flexibility: adjusting to new treatment goals “Patient´s choice” – reimboursement chronic care
Incentives for telephone follow ups Self care
Research question(s) Publication possibilities
![Page 16: Presentation, Harvard, Value Based Care](https://reader036.vdocuments.net/reader036/viewer/2022070317/556e6eefd8b42a795d8b4746/html5/thumbnails/16.jpg)
16
Thank You!
Sofia Ernestam, [email protected] Anna Essén, [email protected] Martin Neovius, [email protected]